Raleigh, NC, United States of America

Andrew Spaltenstein

This inventor holds 16 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in HIV Treatment Innovations. Top assignees: Vertex Pharmaceuticals, Inc., Viiv Healthcare Company, Janssen Sciences Ireland Unlimited Company. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Spaltenstein. Retrieved from https://idiyas.com/inventor/andrew-spaltenstein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 68.8

 

Average Co-Inventor Count = 6.8

ph-index = 5

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 1999-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Combination Therapy
HIV Infections
AIDS
Aspartyl Protease
Inhibitors
Sulphonamide Derivatives
Prodrugs
Regimens
Protease Inhibitors
Therapeutics
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andrew Spaltenstein

Introduction

Andrew Spaltenstein is a notable inventor based in Raleigh, NC, who has made significant contributions to the field of medicine, particularly in the treatment of HIV infections and AIDS. With a total of 15 patents to his name, Spaltenstein's work reflects a commitment to advancing healthcare solutions.

Latest Patents

Among his latest patents is a method for treating HIV that involves intramuscular administration of a combination of cabotegravir and rilpivirine. This innovative approach allows for administration once every four weeks or less frequently, providing an option to discontinue the first oral anti-retroviral regimen. This method represents a significant advancement in the management of HIV infections.

Career Highlights

Throughout his career, Andrew Spaltenstein has worked with prominent companies in the pharmaceutical industry, including Vertex Pharmaceuticals, Inc. and ViiV Healthcare Company. His experience in these organizations has contributed to his expertise in developing effective treatment regimens for HIV.

Collaborations

Some of his notable coworkers include Michael Robin Hale and Eric Steven Furfine, who have collaborated with him on various projects aimed at improving patient outcomes in HIV treatment.

Conclusion

Andrew Spaltenstein's innovative work and dedication to advancing medical treatments have made a significant impact in the field of healthcare. His contributions continue to influence the way HIV infections are managed, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…